RCT | Brentuximab Vedotin with chemotherapy in pediatric high-risk Hodgkin’s Lymphoma.

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Targeted therapy for children with high-risk Hodgkin lymphoma reduces relapse rates, trial shows – News Medical